Cellular Pathology Market Unveiled: Insights, Segmentation, and Growth Projections (2033)-FMI Projection

In 2022, the global cellular pathology market was worth US$ 32.7 billion, and by 2033, it is anticipated to be worth US$ 78.3 billion. With a value share of roughly 48.0%, services led the product and services market globally in 2022. From 2023 to 2033, they are projected to grow at a CAGR of nearly 7.5%.

Cellular pathology is a diagnostic service that examines tissue specimens collected from patients during surgical procedure or post-mortem examination. Cellular pathology deals with the microscopic analysis of tissue samples and cells. Under this, sample preparation and processing includes fixation, staining, sectioning and slide mounting, using equipment such microtomes and cryostats. The cellular pathology is sometimes used as a synonym for cytopathology.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-6869

The process is carried out if a patient contains a wellness, inflammation, a cancer or a non-cancerous growth, by observing the means that the cells are organized.  Histopathology and cytopathology are key diagnostic tests in the initial detection and diagnosis of cancer and other diseases supported by modern molecular techniques. Cellular pathologists are able to provide information on prognosis and help to appropriately direct therapies in post diagnostic treatment.

The cellular pathology service providers provides routine histopathological diagnosis using both standard techniques and advanced diagnostics including immunocytochemistry, fluorescent in-situ hybridisation (FISH), and polymerase chain reaction (PCR), using electron microscopy. Neuropathology is another diagnostic service, provides a specialist histopathology service. Most specimens are brain- and spinal cord tumours and epilepsy lobectomies. Diagnostic biopsies are peripheral nerves and muscle biopsies, CSF cytology and serum screening for anti-neuronal antibodies.

Cellular Pathology Market: Dynamics

The Cellular pathology market is expected to mark a significant growth in the coming few years due to high probability of increase in number of cancer patient. Histopathology and cytopathology have been the main tools utilized in the diagnosis of cancer. The increased demand for pathology services is one of the major driving factor. Addition to this, government support and technological advancement are also boosting the growth of this market.

However, there are some restraining factors which are restricting the growth of this market. Such as to comply with guidelines for cancer case reporting and with the various recommendations of specimen handling and additional testing, the need to improve turnaround time as a critical element in clinical management; and the need to comply with the statutory requirements of the various laboratory accreditation and quality assurance regulatory bodies.

Cellular Pathology Market: Overview

The global market for Cellular pathology market is expected to witness high growth over the forecast period. The high demand of Histopathology diagnosis due to increasing number of cancer patients. Histopathology refers to the examination of a biopsy or surgical specimen by a pathologist, in clinical medicine. The specimen has been processed and histological sections have been placed onto glass slides. This diagnosis provides the exact results of presence of disease in body. This is very necessary process to avoid error arising in the diagnostic phase, among the clinician and the pathologists.

In developed countries, scientists and health researchers are addressing the threat of cancer to humans by attempting to provide appropriate service to end users.

Key Companies Profiled:

• Leica Biosystems Nussloch GmbH (Danaher Corporation)
• BioGenex
• Hologic, Inc.
• Epredia
• Sakura Finetek
• F. Hoffmann-La Roche Ltd.
• Merck KGaA
• Gestalt Diagnostics
• Carl Zeiss AG
• Olympus Corporation
• Abbott Laboratories Inc.
• NeoGenomics Laboratories

Key Market Segments:

By Product:

• Instruments
• Microtomes & Cryostat
• Pathology Workstations
• Slide Strainers
• Tissue Processers
• Other Instruments
• Consumables
• Fixation Solutions and Stains
• Glass Slides & Cover Slips
• Sample Chambers
• Cassettes
• Reagents & Antibodies
• Probes & Kits
• Other Consumables
• Services
• Cytopathology
• Histopathology

By Application:

• Disease Diagnosis
• Drug Discovery and Development
• Therapeutic Research

By End User:

• Hospitals
• Diagnostic Laboratories
• Academic Research Institutes

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Unlock Tailored Insights: Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-6869

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube